Genetic control of interleukin-4-induced activation of the human signal transducer and activator of transcription 6 signaling pathway

Human Immunology

Volumn 64, Issue 4, 2003, Pages 402-415

  Zhang, Wen Jie ^a   Koltun, Walter A ^a   Tilberg, Anna F ^a   Thompson, Jennifer L ^a   Chorney, Michael J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

CD23; IBD; IL 4; QTL; Stat6

Indexed keywords

CD23 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT6 PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CANCER; CONTROLLED STUDY; DOMINANT INHERITANCE; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION REGULATION; GENOTYPE; MULTIFACTORIAL INHERITANCE; NONHUMAN; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SIGNAL TRANSDUCTION;

EID: 0037379876     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00002-8     Document Type: Article

References (46)

1. Leonard WJ, O'Shea JJ: JAKS and STATS: biological implications. Annu Rev Immunol 16:293, 1998.
2. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE: The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701, 1999.
3. Rothstein TL: Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res 10:245, 2000.
4. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701, 1994.
5. Simard J, Jingras S: Crucial role of cytokines in sex steroid formation in normal and tumoral tissues. Mol Cell Endocrinol 171:25, 2001.
6. Levings MK, Schrader JW: IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol 162:5224, 1999.
7. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN: Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630, 1996.
8. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S: Essential role of Stat6 in IL-4 signalling. Nature 380:627, 1996.
9. Darnell Jr JE: STATs and gene regulation. Science 277: 1630, 1997.
10. Shirakawa I, Deichmann KA, Izuhara I, Mao I, Adra CN, Hopkin JM: Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 21:60, 2000.
11. Ostrand-Rosenberg S, Grusby MJ, Clements VK: Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol 165:6015, 2000.
12. Kacha AK, Fallarino F, Markiewicz MA, Gajewski TF: Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice. J Immunol 165:6024, 2000.
13. Yang SY, Milford E, Hammerling U, Dupont B: Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: the B-cell line panel. In Dupont B (ed): Immunobiology of HLA. Proceedings of the Tenth International Histocompatibility Workshop, Vol. 1. New York, Springer-Verlag, 1989.
14. Koltun WA, Poritz LS, Tilberg AF, Boehmer S, Page MJ, Ort S, Zhang WJ: The creation of a highly uniform familial inflammatory bowel disease (IBD) registry [Abstract]. Dis Colon Rectum 44:A3, 2001.
15. Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, Niho Y, Harada N: Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 271:619, 1996.
16. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991.
17. Ohmori Y, Hamilton TA: Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms. J Biol Chem 275:38095, 2000.
18. Ohmori Y, Smith Jr MF, Hamilton TA: IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 157:2058, 1996.
19. Zhang WJ, Degli-Esposti MA, Cobain TJ, Cameron PU, Christiansen FT, Dawkins RL: Differences in gene copy number carried by different MHC ancestral haplotypes: quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med 171:2101, 1990.
20. Sambrook J, Fritsch E, Maniatis T: Detection and analysis of proteins expressed from cloned genes. In: Sambrook J, Fritsch E, Maniatis T (eds): Molecular Cloning: A Laboratory Manual. Ed 2. New York: Cold Spring Harbor Laboratory Press, 1989; 3.
21. Zhang WJ, Kay PH, Cobain TJ, Dawkins RL: C4 allotyping on plasma or serum: application to routine laboratories. Hum Immunol 21:165, 1988.
22. Mikita T, Daniel C, Wu P, Schindler U: Mutational analysis of the STAT6 SH2 domain. J Biol Chem 273: 17634, 1998.
23. Ryan JJ, McReynolds LJ, Huang H, Nelms K, Paul WE: Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. J Immunol 161:1811, 1998.
24. Losman J, Chen XP, Jiang H, Pan PY, Kashiwada M, Giallourakis C, Cowan S, Foltenyi K, Rothman P: IL-4 signaling is regulated through the recruitment of phosphatases kinases and SOCS proteins to the receptor complex. Cold Spring Harb Symp Quant Biol 64:405, 1999.
25. Zhang WJ, Koltun WA, Tilberg AF, Page MJ, Chorney MJ: Absence of Gαi2 codon 179 oncogene mutations in inflammatory bowel disease. Inflamm Bowel Dis 6:103, 2000.
26. White JA, McAlpine PJ, Antonarakis S, Cann H, Eppig JT: Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics 45:468, 1997.
27. Griffiths AJ, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM: Extensions of Mendelian analysis. In: Griffiths J, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM (eds): An Introduction to Genetic Analysis. Ed 6. New York: Freeman and Co., 1996.
28. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993.
29. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ: Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65, 1995.
30. Mitsuyasu H, Izuhara K, Mao XQ, Gao PS, Arinobu Y: Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 19:119, 1998.
31. Mitsuyasu H, Yanagihara Y, Mao XQ, Gao PS, Arinobu Y, Ihara K, Takabayashi A, Hara T, Enomoto T, Sasaki S, Hamasaki N, Shirakawa T, Hopkin JM, Izuhara K: Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. J Immunol 162:1227, 1999.
32. Kruse S, Japha T, Tedner M, Sparholt SH, Forster J, Kuehr J, Deichmann KA: The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 96:365, 1999.
33. Calender A, Billaud M, Aubry JP, Banchereau J, Vuillaume M, Lenoir GM: Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci U S A 84:8060, 1987.
34. Thorley-Lawson DA, Backcock GJ: A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci 65:1433, 1999.
35. Thorley-Lawson DA, Mann KP: Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med 162:45, 1985.
36. Skinnider BF, Elia AJ, Gascoyne RD, Patterson B, Trumper L, Kapp U, Mak TW: Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99:618, 2002.
37. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182, 1998.
38. MacDonald TT, Monteleone G, Pender SL: Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 51:2, 2000.
39. Zhang WJ, Koltun WA: Genetic factors in the etiology and potential management of IBD. Semin Colon Rectal Surg 12:2, 2001.
40. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP: Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14:199, 1996.
41. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, Delmonte T, Kocher K, Miller K, Guschwan S, Kulbokas EJ, O'Leary S, Winchester E, Dewar K, Green T, Stone V, Chow C, Cohen A, Langelier D, Lapointe G, Gaudet D, Faith J, Branco N, Bull SB, McLeod RS, Griffiths AM, Bitton A, Greenberg GR, Lander ES, Siminovitch KA, Hudson TJ: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29:223, 2001.
42. Aithal GP, Day CP, Leathart J, Daly AK, Hudson M: Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun 2:44, 2001.
43. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT: Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun 2:287, 2001.
44. Zhang WJ, Tilberg AF, Poritz LS, Chorney MJ, Koltun WA: Defective Stat6 signaling pathway in familial inflammatory bowel disease (IBD) [Abstract]. Gastroenterology 120(Suppl 1):A516, 2001.
45. Amoli M, Ollier WE, Hajeer AH: A novel PCR-RFLP assay for the detection of a polymorphism in the 3′ of STAT6 gene. Genes Immun 1:349, 2000.
46. Kruse S, Braun S, Deichmann KA: Distinct signal transduction processes by IL-4 and IL-13 and influences from the Q551R variant of the human IL-4 receptor alpha chain. Respir Res 3:24, 2002.